More than 45 encapsulated cell therapies and encapsulation technologies are being evaluated across different phases of development by stakeholders across the globe, claims Roots Analysis
Extensive research on cell encapsulation strategies has enabled the development of a variety of technologies capable of immobilizing / enclosing therapeutic entities within biocompatible matrices / carriers.
117
views

Extensive research on cellencapsulation strategies has enabled the development of a variety oftechnologies capable of immobilizing / enclosing therapeutic entities withinbiocompatible matrices / carriers. Such products offer a myriad of advantages,and have demonstrated the capability to address existing challenges related tocell therapies and certain other types of interventions as well.

 

To order this 500+ page report, which features 170+ figuresand 395+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/cell-encapsulation-focus-on-therapeutics-and-technologies-2019-2030-/249.html

 

The USD 3.7 billion (by 2030)financial opportunity within the encapsulated cell therapies and encapsulationtechnologies market has been analyzed across the following segments:

§  Type of licensing deal payment

§   Upfront payment

§   Milestone payment

 

§  Therapeutic area

§   Metabolic disorder

§   Neurological disorder

§   Ophthalmic disorder

§   Oncological disorder

 

§  Target disease indication

§   Ataxia telangiectasia

§   Breast cancer

§   Diabetes

§   Glaucoma

§   Head and neck cancer

§   Macular telangectasia

§   Pancreatic cancer

§   Parkinson's disease

§   Retinitis pigmentosa

 

§  Type of encapsulation material used

§   Alginate-based microcapsule

§   Cellulose hydrogel

§   Medical-grade plastic

§   Red blood cell

 

§  Key geographical region

§   North America

§   Europe

§   Asia-Pacific and rest of the world

 

The Cell Encapsulation:Focus on Therapeutics and Technologiesv, 2019-2030 reportfeatures the following companies, which we identified to be key players in thisdomain: 

§ ALTuCELL

§ Azellon CellTherapeutics

§ Beta-Cell

§ Betalin Therapeutics

§ CellProtectBiotechnology

§ Diatranz Otsuka

§ Encellin

§ EryDel

§ Gloriana Therapeutics

§ Living CellTechnologies

§ MaxiVAX

§ NeurotechPharmaceuticals

§ PharmaCyte Biotech

§ Semma Therapeutics

§ Sernova

 

Table of Contents

 

1.         Preface


2.         ExecutiveSummary

 

3.         Introduction

 

4.         CurrentMarket Landscape

 

5.         EncapsulatedCell Therapies and Encapsulation Technologies for Metabolic Disorders: CompanyProfiles

 

6.         EncapsulatedCell Therapies and Encapsulation Technologies for Non-Metabolic Disorders:Company Profiles

 

7.         PatentAnalysis

 

8.         ClinicalTrial Analysis

 

9.         RecentPartnerships

 

10.       Fundingand Investment Analysis

 

11.       GrantAnalysis

 

12.       PotentialStrategic Partners

 

13.       MarketForecast

 

14.       Conclusion

 

15.       ExecutiveInsights

 

16.       Appendix1: Tabulated Data

 

17.       Appendix2: List of Companies and Organizations

 

To purchase a copy, please visit https://rootsanalysis.com/reports/view_document/cell-encapsulation-focus-on-therapeutics-and-technologies-2019-2030/249.html

 

Contact:

Gaurav Chaudhary

+1 (415) 800 3415

+44 (122) 391 1091
Gaurav.Chaudhary@rootsanalysis.com